This milestone underscores our unwavering commitment to develop novel, transformational therapies that may help address significant unmet need for patients living with autoantibody-driven diseases." ...

The findings were reported in Science Translational Medicine. The researchers wanted to measure autoantibody levels in nasal ...

A specific autoantibody signature was seen in a subset of people with multiple sclerosis (MS) long before clinical symptoms ...

Johnson & Johnson announced that the U.S. Food and Drug Administration has granted nipocalimab Breakthrough Therapy designation for the ...

The US Food and Drug Administration (FDA) has awarded the second breakthrough therapy designation (BTD) to Johnson & ...

Unfortunately, the diagnostic and prognostic use of thyroid autoantibody measurements is hampered by technical problems as discussed below. Although autoantibody tests have inherent clinical ...

In addition, markers for inflammation and autoantibody testing (like RF and anti-CCP) are negative in fibromyalgia because ...

Bollywood actor Arjun Kapoor opened up about his diagnosis with Hashimoto’s disease an autoimmune thyroid condition Read to ...

Nipocalimab is a fully human monoclonal antibody that blocks FcRn and decreases levels of circulating IgG antibodies.

Also early in 2024, researchers uncovered a specific autoantibody signature that was evident in some MS patients 5 years ...

Alzheimer's disease is the most common cause of dementia in the elderly and is characterized by abnormal deposits of amyloid-beta and tau proteins in the brain. This disease has a ...

Canada is facing a shortage of health professionals, particularly in rural and remote communities that face unique challenges ...